Levebon

Levetiracetam, the active ingredient in Levebon, is an anticonvulsant presented as an intravenous solution for intravenous use. It is indicated for the management of epilepsy and helps reduce the frequency of seizures in adult and pediatric patients who require parenteral therapy. The medication is formulated for hospital settings where rapid plasma concentrations are needed.

GNH USA supplies Levebon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this essential antiepileptic agent. Our distribution network ensures timely delivery and compliance with local regulations.

Levetiracetam is an anticonvulsant used to control seizures in epilepsy.

- Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy. - Generalized tonic‑clonic seizures: provides adjunctive control in generalized epilepsy. - Myoclonic seizures: helps manage seizure activity in specific epilepsy syndromes.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or drowsiness. - Headache: mild to moderate pain in the head region. - Irritability: mood changes including agitation. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: rare skin disorder with blistering. - Suicidal ideation: thoughts of self‑harm or suicide. - Blood dyscrasias: abnormal blood counts or clotting issues. - Severe depression: marked mood disturbances requiring medical attention. - Hepatic failure: signs of liver dysfunction such as jaundice.

When using Levebon, consider the following safety measures.

- Renal impairment: adjust dosing and monitor renal function. - Hepatic dysfunction: evaluate liver enzymes before and during therapy. - Psychiatric symptoms: observe for mood changes, depression, or suicidal thoughts. - Concomitant CNS depressants: use with caution due to additive sedation. - Pregnancy: risk unknown; weigh benefits against potential hazards. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levetiracetam may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: can reduce therapeutic effect of levetiracetam. - Topiramate: increased risk of central nervous system depression.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance sedative effects. - Other antiepileptics: dose adjustments may be required based on clinical response.